Mesothelioma.com Resources for Patients and their Families

Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma

Brief Summary

Asbestos defines a group of naturally occurring mineral silicate fibers which are easily inhaled, resulting in a variety of diseases of the respiratory system including lung cancer and malignant mesothelioma. Despite some advances in treatment, there has been little impact on overall survival for both lung cancer and mesothelioma in the past 20 years in great part because patients usually present with disease at an advanced and incurable stage. This study aims to develop and implement a low-dose computed tomography (LDCT) screening approach for lung cancer and mesothelioma in asbestos-exposed workers in Alberta.

Tracking Information
First Received DateNovember 27, 2014
Last Changed DateSeptember 6, 2016
Start DateApril 2015
Anticipated Primary Completion DateDecember 2019
Primary Outcome Measures

Change in SF-12 quality of life score [Time Frame: Baseline vs. 14 days post receipt of screen results.]

Secondary Outcome Measures

Change in EQ-5D and STAI [Time Frame: Baseline vs. 14 days post receipt of screen results.]

Lung cancer detection rate [Time Frame: 3 years]

Mesothelioma detection rate [Time Frame: 3 years]

Descriptive Information
PhasePhase 2
Study TypeInterventional
Condition
  • Lung Cancer
  • Mesothelioma
Intervention
  • Procedure: Low-dose computed tomography Annual scan x3
  • Procedure: Low-dose computed tomography Baseline scan only
Study Arms / Comparison Groups2 / 0
Detailed Description

In Canada, lung cancer is the primary cause of cancer mortality above the next three culprits combined (breast, colon and prostate cancer). Cigarette smoking is the most important risk factor in the development of lung cancer. Another population of particular interest in Alberta involves workers with occupational exposure to asbestos as asbestos and tobacco exposure results in a synergistic effect on lung cancer risk. Mesothelioma is a rare cancer of the lining of the lung with poor prognosis of which 80% of cases are believed to be related to asbestos exposure.

Unfortunately, despite some advances in treatment, there has been little impact on overall survival for both lung cancer and mesothelioma in the past 20 years in great part because patients usually present with disease at an advanced and incurable stage. Additional strategies are desperately needed to reduce the morbidity and mortality associated with this disease.

The objectives of this study are to develop and implement a LDCT screening approach for lung cancer and mesothelioma in asbestos-exposed workers in Alberta; to determine participants' motivation and expectations associated with a screening program, their satisfaction with the program, and the psychosocial consequences of the screening program; to determine the accuracy of a lung cancer risk prediction model modified to include asbestos exposure; and to determine the 3-year clinical incidence of lung cancer in asbestos-exposed individuals interested in lung cancer screening but who do not meet minimal risk threshold.

The investigators will offer a combined lung cancer and mesothelioma screening program for 200 Alberta asbestos-exposed workers based on low-dose CT scanning.

Recruitment Information
Recruitment StatusRecruiting
Anticipated Enrollment200
GenderAll
Ages50 Years - 80 Years
Accepts Healthy VolunteersAccepts Healthy Volunteers
Contact Alain Tremblay, MD
Email: atrembla@ucalgary.ca
Phone: 403-210-3866
Eligibility Criteria

Inclusion Criteria:

- Age 50 - 80 years (either gender, any ethnic group)

- Documented exposure to asbestos for at least one year, at least 10 years prior to study entry

- Ability to provide informed consent and participate in study procedures

Exclusion Criteria:

- Any medical condition, such as severe heart disease (e.g. unstable angina, chronic congestive heart failure), severe lung disease or lung disease requiring supplemental oxygen, solid organ transplant, that in the opinion of the physician unlikely to benefit from screening due to shortened life-expectancy from the co-morbidities or inability to tolerate diagnosis and treatment of a screen detected abnormality

- Have been previously diagnosed with lung cancer or mesothelioma

- Have had other cancer within the past 5 years with the exception of the following cancers: non-melanomatous skin cancer, localized prostate cancer, carcinoma in situ (CIS) of the cervix, or superficial bladder cancer. Treatment of the exceptions must have ended >6 months before registration into this study

- Pregnancy

- CT scan of the chest in the past 2 years

- Unwilling to have a LDCT of chest

- Unwilling to sign a consent

Administrative Information
NCTIDNCT02385812
Responsible Party,
SponsorUniversity of Calgary
Verification DateSeptember 2016
Mesothelioma Doctors by State
  • Breaking News
  • Emerging Clinical Trials
  • Delivered within 24 hrs

Yes   No

Mesothelioma Cancer Alliance Blog

FEATURED CONTENT:


RECENT POSTS:

A First Look into the EPA’s Risk Evaluation of Asbestos

Remembering Mesothelioma Victims in the UK

The Challenges of Research in Immunotherapy

Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To: